| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| R&D Expense | $153K | -2.2% |
| SG&A Expense | $81K | +26.3% |
| Operating Income | -$514K | +22.8% |
| Income Tax | $0 | — |
| Net Income | -$507K | +49.3% |
| EPS (Basic) | -$0.06 | -500.0% |
| EPS (Diluted) | -$0.06 | -500.0% |
| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $75K | -58.5% |
| Accounts Receivable | $5K | -20.6% |
| Current Assets | $115K | -65.4% |
| Total Assets | $125K | -63.4% |
| Current Liabilities | $325K | +2.9% |
| Stockholders' Equity | -$198K | -813.3% |
| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$407K | +38.9% |
| Investing Cash Flow | $76K | -87.0% |
| Financing Cash Flow | $226K | — |